Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
about
Molecular biology of lung cancer: clinical implicationsRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesTherapeutic targeting of replicative immortalityBreast cancer vaccines: a clinical reality or fairy tale?Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.Immunity to stemness genes in human cancer.Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.Telomere maintenance mechanisms in cancer: clinical implicationsChondrocyte senescence and telomere regulation: implications in cartilage aging and cancer (a brief review).Gene therapy for gastric cancer: a review.Novel approaches to therapeutic cancer vaccines.Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.Targeting telomerase-expressing cancer cells.Telomere and telomerase as targets for anti-cancer and regeneration therapies.Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.Premature senescence of endothelial cells: Methusaleh's dilemma.Tumor-associated antigens in breast cancer.Targeting telomerase for cancer therapeuticsTelomerase-based immunotherapy of cancer.Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer.Telomere biology of pediatric cancer.Prospects and challenges of building a cancer vaccine targeting telomeraseThe antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro.Telomerase as a universal tumor antigen for cancer vaccines.Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.Telomerase structure paves the way for new cancer therapies.From bench to bedside: the growing use of translational research in cancer medicine.Targeting telomerase in hematologic malignancy.Is telomerase a viable target in cancer?Vaccines targeting cancer stem cells: are they within reach?Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.Antigen-specific T cell therapies for cancer.Mannan-modified adenovirus as a vaccine to induce antitumor immunity.Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia.Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.The Emerging Roles for Telomerase in the Central Nervous System.Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata.
P2860
Q24610335-72EE6510-7725-429E-85DA-7550547F9797Q26744271-D8B672E6-D328-4267-BB23-F190DE83B7A6Q27027457-C610B07D-FC6E-428D-9C91-CF816335198AQ30351838-E65AD8AC-E118-4894-BFDE-229B1A57B7C9Q31022597-83F6E81B-D991-43C6-BE41-0C0BC1F1165BQ33943241-8B30C652-4D3F-4BE1-BFAA-AA9F9573B323Q34151620-833258D1-C165-4AF3-A8CC-E3B60AE06265Q34426966-E7341786-B057-41BA-BC0A-2D77C0E411A5Q34785917-EA8EEEC5-852D-44FE-9B09-A43CA1D292E0Q35579112-95095662-B1A5-421B-8686-325BF8D8C0CBQ35623327-DA3C6E9D-F695-4363-9BB8-C4827FDE99FEQ35753931-58D6B683-D45B-4A40-9C2E-9757C77C27F8Q36017631-C5E119AA-B774-4068-AFBF-DE4466190801Q36103191-FC0E82F8-9AD5-48B4-8982-09B6B04181FEQ36239656-0747A7AA-80BD-4251-8414-4AE42777A9D6Q36444277-BCD46A56-7E4E-4D42-941C-B3232FF0D885Q36449259-47BA83E0-EDB9-4B44-851E-EF3D1742811CQ36484571-6034C665-030D-4954-8D2E-39B8A8D52888Q36600251-91825CE3-73FB-4B32-820E-AB7699B7D2DDQ36643661-3645D3AF-30E6-47F4-8E06-F3FFAC4DD4FDQ36832376-457BC271-E90B-4A45-BF03-5BE4A7196573Q36918394-E840903D-13BC-427A-B7B3-2F4625A0376DQ36930009-87ACA339-BB40-4B80-AC5F-63FE14458290Q37259573-F323101B-3DE9-486D-9F6F-8798DA12DAAAQ37403114-0314981E-3A80-4B07-ABB0-45CFAA60B86EQ37414350-1DF7555F-53E7-486A-ADF2-582F9FF815EAQ37698244-6F2AF420-E5F2-4184-BBD1-CEA6268A44DEQ37750789-D3DE45C7-C4FC-47C4-86C5-EEC7FB1AE1A6Q37908470-DBDF85F7-E36A-41D6-AE27-74B2EABB23C4Q37939527-FEBB93D2-B053-4C7B-9447-8D1A4974CB28Q38402026-4268D145-480F-409B-8298-FD6E96E658D6Q38544740-9BC5C763-A1CF-45B6-A4C7-46BCE4A0FD2CQ40243921-83AFF73C-073F-4F35-9988-0C9CDFE2ADF9Q41279759-1E7E8FF0-2CD5-492B-A274-FB4F2EA2FA6EQ47993135-1F6B147B-6FF8-4B35-8CF2-4E0DE12AE70CQ55096010-8A69F8BC-71DF-4BB9-948A-CF6035E73EFCQ55209716-6B7215B6-267E-4E63-9092-2D028A8EF3BE
P2860
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@ast
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@en
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@nl
type
label
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@ast
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@en
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@nl
prefLabel
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@ast
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@en
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@nl
P2860
P356
P1433
P1476
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
@en
P2093
Robert H Vonderheide
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205074
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1045211666